These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11392547)

  • 1. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors.
    Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL
    Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.
    Lau CK; Black WC; Belley M; Chan C; Charleson S; Denis D; Gauthier JY; Gordon R; Guay D; Hamel P; Kargman S; Leblanc Y; Mancini J; Ouellet M; Percival D; Prasit P; Roy P; Skorey K; Tagari P; Vickers P; Wong E
    Adv Exp Med Biol; 1997; 407():73-8. PubMed ID: 9321934
    [No Abstract]   [Full Text] [Related]  

  • 3. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ
    J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-inflammatory activity of alkyl/arylidene-2-aminobenzothiazoles and 1-benzothiazol-2-yl-3-chloro-4-substituted-azetidin-2-ones.
    Khedekar PB; Bahekar RH; Chopade RS; Umathe SN; Rao AR; Bhusari KP
    Arzneimittelforschung; 2003; 53(9):640-7. PubMed ID: 14558438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors.
    Friesen RW; Brideau C; Chan CC; Charleson S; Deschênes D; Dubé D; Ethier D; Fortin R; Gauthier JY; Girard Y; Gordon R; Greig GM; Riendeau D; Savoie C; Wang Z; Wong E; Visco D; Xu LJ; Young RN
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2777-82. PubMed ID: 9873621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COX-2 inhibition: latest on NSAID].
    Z Orthop Ihre Grenzgeb; 1997; 135(1):Oa20-1. PubMed ID: 9199064
    [No Abstract]   [Full Text] [Related]  

  • 9. Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
    Arisawa M; Kasaya Y; Obata T; Sasaki T; Nakamura T; Araki T; Yamamoto K; Sasaki A; Yamano A; Ito M; Abe H; Ito Y; Shuto S
    J Med Chem; 2012 Sep; 55(18):8152-63. PubMed ID: 22916727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling.
    Vigorita MG; Ottanà R; Monforte F; Maccari R; Monforte MT; Trovato A; Taviano MF; Miceli N; De Luca G; Alcaro S; Ortuso F
    Bioorg Med Chem; 2003 Mar; 11(6):999-1006. PubMed ID: 12614885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors.
    Hu W; Guo Z; Chu F; Bai A; Yi X; Cheng G; Li J
    Bioorg Med Chem; 2003 Apr; 11(7):1153-60. PubMed ID: 12628642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2.
    Lazer ES; Sorcek R; Cywin CL; Thome D; Possanza GJ; Graham AG; Churchill L
    Bioorg Med Chem Lett; 1998 May; 8(10):1181-6. PubMed ID: 9871731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
    Sawdy R; Pan H; Sullivan M; Bennett P
    J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors.
    Hashimoto H; Maeda K; Ozawa K; Haruta J; Wakitani K
    Bioorg Med Chem Lett; 2002 Jan; 12(1):65-8. PubMed ID: 11738574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and receptor docking studies of N-substituted indole-2-carboxylic acid esters as a search for COX-2 selective enzyme inhibitors.
    Olgen S; Akaho E; Nebioglu D
    Eur J Med Chem; 2001 Sep; 36(9):747-70. PubMed ID: 11672885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of cyclooxygenase-2 selectivity into ketoprofen.
    Palomer A; Pascual J; Cabré M; Borràs L; González G; Aparici M; Carabaza A; Cabré F; García ML; Mauleón D
    Bioorg Med Chem Lett; 2002 Feb; 12(4):533-7. PubMed ID: 11844666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors.
    Dubé D; Brideau C; Deschênes D; Fortin R; Friesen RW; Gordon R; Girard Y; Riendeau D; Savoie C; Chan CC
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1715-20. PubMed ID: 10397507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.